human | Q5 |
P856 | official website | https://abdn.pure.elsevier.com/en/en/persons/felix-grassmann(26b9bd44-c87f-4a62-b17d-8480a43d2ca2).html |
P496 | ORCID iD | 0000-0003-1390-7528 |
P1153 | Scopus author ID | 42661366400 |
P108 | employer | University of Aberdeen | Q270532 |
P735 | given name | Felix | Q18177136 |
Felix | Q18177136 | ||
P106 | occupation | researcher | Q1650915 |
Q35567948 | A Candidate Gene Association Study Identifies DAPL1 as a Female-Specific Susceptibility Locus for Age-Related Macular Degeneration (AMD). |
Q52929405 | A Deep Learning Algorithm for Prediction of Age-Related Eye Disease Study Severity Scale for Age-Related Macular Degeneration from Color Fundus Photography. |
Q34156202 | A circulating microrna profile is associated with late-stage neovascular age-related macular degeneration |
Q36556369 | A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants |
Q52590951 | A mega-analysis of expression quantitative trait loci (eQTL) provides insight into the regulatory architecture of gene expression variation in liver. |
Q98881003 | A mega-analysis of expression quantitative trait loci in retinal tissue |
Q36249287 | Age-related macular degeneration associated polymorphism rs10490924 in ARMS2 results in deficiency of a complement activator |
Q30489873 | An Eye on Age-Related Macular Degeneration: The Role of MicroRNAs in Disease Pathology. |
Q92238292 | Assessment of Novel Genome-Wide Significant Gene Loci and Lesion Growth in Geographic Atrophy Secondary to Age-Related Macular Degeneration |
Q98780359 | Association between breast cancer risk and disease aggressiveness: characterizing underlying gene expression patterns |
Q59208956 | Cell type-specific complement expression from healthy and diseased retinae |
Q35593465 | Clinical and genetic factors associated with progression of geographic atrophy lesions in age-related macular degeneration |
Q35155368 | Common synonymous variants in ABCA4 are protective for chloroquine induced maculopathy (toxic maculopathy). |
Q93044111 | Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial |
Q57454553 | Conduct and Quality Control of Differential Gene Expression Analysis Using High-Throughput Transcriptome Sequencing (RNASeq) |
Q92851671 | Cost-effective molecular inversion probe-based ABCA4 sequencing reveals deep-intronic variants in Stargardt disease |
Q91045529 | Deep-intronic ABCA4 variants explain missing heritability in Stargardt disease and allow correction of splice defects by antisense oligonucleotides |
Q58803874 | Evaluation of serum sphingolipids and the influence of genetic risk factors in age-related macular degeneration |
Q36205759 | Features of Age-Related Macular Degeneration in the General Adults and Their Dependency on Age, Sex, and Smoking: Results from the German KORA Study |
Q37724216 | Genetic pleiotropy between age-related macular degeneration and 16 complex diseases and traits |
Q38199030 | Genetic risk models in age-related macular degeneration. |
Q37265929 | Identification of a rare coding variant in complement 3 associated with age-related macular degeneration |
Q33992629 | In-depth characterisation of Retinal Pigment Epithelium (RPE) cells derived from human induced pluripotent stem cells (hiPSC). |
Q92328828 | Insights into the loss of the Y chromosome with age in control individuals and in patients with age-related macular degeneration using genotyping microarray data |
Q52359171 | Investigating the modulation of genetic effects on late AMD by age and sex: Lessons learned and two additional loci. |
Q34292742 | Modelling the genetic risk in age-related macular degeneration. |
Q36810588 | Multiallelic copy number variation in the complement component 4A (C4A) gene is associated with late-stage age-related macular degeneration (AMD). |
Q37610127 | Mutation Spectrum of the ABCA4 Gene in 335 Stargardt Disease Patients From a Multicenter German Cohort-Impact of Selected Deep Intronic Variants and Common SNPs. |
Q88552110 | Pleiotropic Effects of Risk Factors in Age-Related Macular Degeneration and Seemingly Unrelated Complex Diseases |
Q34307274 | Rare and common variants in extracellular matrix gene Fibrillin 2 (FBN2) are associated with macular degeneration |
Q40460645 | Recombinant Haplotypes Narrow the ARMS2/HTRA1 Association Signal for Age-Related Macular Degeneration. |
Q52312110 | Recurrent structural variation, clustered sites of selection, and disease risk for the complement factor H (CFH) gene family. |
Q89179502 | Spectral Domain Optical Coherence Tomography Allows the Unification of Clinical Decision Making for the Evaluation of Choroidal Neovascularization Activity |
Q30378420 | Synonymous variants in HTRA1 implicated in AMD susceptibility impair its capacity to regulate TGF-β signaling. |
Q26799625 | Tapping Stem Cells to Target AMD: Challenges and Prospects |
Q64250529 | The agonistic TSPO ligand XBD173 attenuates the glial response thereby protecting inner retinal neurons in a murine model of retinal ischemia |
Q38489459 | The genetics of age-related macular degeneration (AMD)--Novel targets for designing treatment options? |
Q28586433 | The retinitis pigmentosa 28 protein FAM161A is a novel ciliary protein involved in intermolecular protein interaction and microtubule association |
Q37646779 | The role of the complement system in age-related macular degeneration |
Q39322867 | What Does Genetics Tell Us About Age-Related Macular Degeneration? |
Q91211155 | Y chromosome mosaicism is associated with age-related macular degeneration |
Search more.